Ronald M. Kurtz M.D.
President & CEO at RxSight Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: RxSight Inc., 3 years.
RxSight Inc.
Director · President & CEO
Chief executive roles
RxSight Inc.
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 8, 2024 | RxSight Inc. | Open-market sale | −31,250 | $43.50 | $1,359,375 |
| Jan 8, 2024 | RxSight Inc. | Open-market sale | −31,250 | $45.00 | $1,406,250 |
| Dec 27, 2023 | RxSight Inc. | Open-market sale | −22,500 | $41.09 | $924,525 |
| Dec 14, 2023 | RxSight Inc. | Open-market sale | −20,000 | $40.01 | $800,200 |
| Dec 14, 2023 | RxSight Inc. | Open-market sale | −20,000 | $39.40 | $788,000 |
| Feb 10, 2023 | RxSight Inc. | Grant or award | +40,000 | $12.50 | $500,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.